Formic Acid

Formic Acid

SCHEMBL31344342

COc1ncccc1S(N)(=O)=O.O=CO

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 8/20 0.50
PTGES2 Q9H7Z7 1/20 0.46
CA1 P00915 4/20 0.45
CA2 P00918 4/20 0.45
CA9 Q16790 3/20 0.45
MAPK1 P28482 1/20 0.45
FTO Q9C0B1 1/20 0.42
SLC22A12 Q96S37 1/20 0.41
CA5A P35218 1/20 0.41
CA12 O43570 1/20 0.41
LMNA P02545 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TRPV4 Q9HBA0 1/20 0.38
CCR4 P51679 1/20 0.37
APLNR P35414 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL14247346 1.00 NFE2L2 (0.50) NFE2L2PTGES2CA1CA2CA9
SCHEMBL789817 0.92 NFE2L2 (0.52) NFE2L2PTGES2CA1CA2CA9
SCHEMBL29705304 0.92 NFE2L2 (0.52) NFE2L2PTGES2CA1CA2CA9
Trifluoroacetic Acid SCHEMBL14247260 0.82 NFE2L2 (0.48) NFE2L2PTGES2CA1CA2CA9
Formic Acid SCHEMBL14247786 0.80 CA1 (0.50) CA1CA2CA9MAPK1FTO
SCHEMBL27553171 0.78 NFE2L2 (0.52) NFE2L2PTGES2CA1CA2SLC22A12
SCHEMBL31029569 0.78 PTGES2 (0.57) NFE2L2PTGES2CA1CA2CA9
Hydrochloric Acid SCHEMBL28312857 0.77 NFE2L2 (0.51) NFE2L2PTGES2CA1CA2SLC22A12
SCHEMBL30862874 0.76 NFE2L2 (0.54) NFE2L2PTGES2CA1CA2SLC22A12
SCHEMBL14247634 0.76 CA1 (0.51) PTGES2CA1CA2CA9MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025043350-A1 TRIAZOLOPYRIDOPYRIMIDINE AND DIHYDROIMIDAZOPYRIDOPYRIMIDINE DERIVATIVES AS INHIBITORS OF THE GCN2 KINASE, COMPOSITIONS AND USES THEREOF ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2025-03-06 WO disclosed